使用质子泵抑制剂相关的肺炎风险。 - Suppr

Risk of pneumonia associated with proton pump inhibitor use.

作者信息

Watanabe Kenta, Iijima Katsunori

机构信息

Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.

出版信息

J Gastroenterol. 2023 Sep;58(9):945-946. doi: 10.1007/s00535-023-02022-6. Epub 2023 Jul 16.

DOI:10.1007/s00535-023-02022-6

PMID:37454300

Abstract

摘要

相似文献

Risk of pneumonia associated with proton pump inhibitor use.

J Gastroenterol. 2023 Sep;58(9):945-946. doi: 10.1007/s00535-023-02022-6. Epub 2023 Jul 16.

Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.

PLoS One. 2019 May 8;14(5):e0216750. doi: 10.1371/journal.pone.0216750. eCollection 2019.

Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study.

BMJ. 2013 Sep 19;347:f5416. doi: 10.1136/bmj.f5416.

[Nosocomial pneumonia during stress ulcer prophylaxis? - risk of nosocomial pneumonia is increased during stress ulcer prophylaxis].

Dtsch Med Wochenschr. 2013 Nov;138(47):2398. doi: 10.1055/s-0032-1329067. Epub 2013 Nov 12.

Proton pump inhibitor side effects and drug interactions: much ado about nothing?

Cleve Clin J Med. 2011 Jan;78(1):39-49. doi: 10.3949/ccjm.77a.10087.

Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.

Aliment Pharmacol Ther. 2010 Jun;31(11):1165-77. doi: 10.1111/j.1365-2036.2010.04284.x. Epub 2010 Mar 4.

Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.

Trials. 2016 Apr 19;17(1):205. doi: 10.1186/s13063-016-1331-3.

[Long-term use of proton pump inhibitors--really harmless?].

Dtsch Med Wochenschr. 2013 Nov;138(45):2319-21. doi: 10.1055/s-0033-1349562. Epub 2013 Oct 25.

Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults.

J Am Geriatr Soc. 2018 Jul;66(7):1332-1338. doi: 10.1111/jgs.15385. Epub 2018 Apr 20.

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit.

Sci Rep. 2021 Sep 16;11(1):18467. doi: 10.1038/s41598-021-98069-7.

引用本文的文献

Prognostic value of multivariate logistic regression analysis and amyloid A lactate monitoring in patients with severe pneumonia-associated sepsis.

BMC Pulm Med. 2025 Apr 23;25(1):191. doi: 10.1186/s12890-025-03648-3.

本文引用的文献

Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study.

J Gastroenterol. 2023 Aug;58(8):734-740. doi: 10.1007/s00535-023-02007-5. Epub 2023 Jun 14.

Association of Proton Pump Inhibitor Use With All-Cause and Cause-Specific Mortality.

Gastroenterology. 2022 Oct;163(4):852-861.e2. doi: 10.1053/j.gastro.2022.06.067. Epub 2022 Jul 1.

Potent Acid Suppression With Vonoprazan vs Proton Pump Inhibitors Does Not Have Higher Association With Clostridioides difficile Infection.

Am J Gastroenterol. 2021 Aug 1;116(8):1632-1637. doi: 10.14309/ajg.0000000000001309.

Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.

BMJ. 2016 Nov 15;355:i5813. doi: 10.1136/bmj.i5813.

Complications of Proton Pump Inhibitor Therapy.

Gastroenterology. 2017 Jul;153(1):35-48. doi: 10.1053/j.gastro.2017.04.047. Epub 2017 May 19.

The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.

Gastroenterology. 2017 Mar;152(4):706-715. doi: 10.1053/j.gastro.2017.01.031.

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis.

Gut. 2014 Apr;63(4):552-8. doi: 10.1136/gutjnl-2013-304738. Epub 2013 Jul 15.

Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.

Aliment Pharmacol Ther. 2010 Jun;31(11):1165-77. doi: 10.1111/j.1365-2036.2010.04284.x. Epub 2010 Mar 4.

Application of lag-time into exposure definitions to control for protopathic bias.

Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):250-8. doi: 10.1002/pds.1360.

Long-term proton pump inhibitor therapy and risk of hip fracture.

JAMA. 2006 Dec 27;296(24):2947-53. doi: 10.1001/jama.296.24.2947.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Risk of pneumonia associated with proton pump inhibitor use.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献